Paired attack and remission sampling
The same 15 patients were sampled during remission and within six hours of attack onset, reducing confounding from stable between-person characteristics.
↳ Methods §2.2
Abstract
Hereditary angioedema is a disabling, life-threatening condition caused by deficiency (type I) or dysfunction (type II) of the C1 inhibitor protein (C1-INH-HAE) leading to bradykinin accumulation and recurrent episodes of edema attack. Vascular leakage is a complex process sustained by the coordinated production of several permeabilizing factors including vascular endothelial growth factors (VEGFs), angiopoietins (ANGPTs) and phospholipase A2 enzymes (PLA2). We previously reported that patients with C1-INH-HAE in remission have increased plasma levels of VEGFs, ANGPTs and secreted PLA2. In this study, we sought to analyze plasma levels of these mediators in 15 patients with C1-INH-HAE during the acute attack compared to remission. Plasma concentrations of VEGF-A, VEGF-C and VEGF-D were not altered during attack compared to remission. Moreover, VEGF-D concentrations were not altered also in remission phase compared to controls. Concentrations of ANGPT1, a vascular stabilizer, were increased during attacks compared to symptoms-free periods, whereas ANGPT2 levels were not altered. The ANGPT2/ANGPT1 ratio was decreased during angioedema attacks. Platelet activating factor acetylhydrolase activity was increased in patients with C1-INH-HAE in remission compared to controls and was decreased during angioedema attacks. Our results emphasize the complexity by which several vasoactive mediators are involved not only in the pathophysiology of C1-INH-HAE, but also during angioedema attacks and its resolution.
Key Claims
Primary findingSupported
Concentrations of ANGPT1, a vascular stabilizer, were increased during attacks compared to symptoms-free periods, whereas ANGPT2 levels were not altered.
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
paired observations support the direction, but the 15-patient descriptive design limits physiological interpretation
Abstract; Results §3.1; Figure 1B–C
SecondarySupported
Platelet activating factor acetylhydrolase activity was increased in patients with C1-INH-HAE in remission compared to controls and was decreased during angioedema attacks.
reported cross-sectional and paired comparisons support both directions, subject to subgroup selection and acute-phase measurement limitations
Abstract; Results §3.2; Figure 2A,E
SecondaryTentative
Plasma concentrations of VEGF-A, VEGF-C and VEGF-D were not altered during attack compared to remission.
the paired design addresses the comparison, but 15 patients provide limited power for a null finding
Abstract; Results §3.1; Figure 1A,E,G
SecondarySupported
The ANGPT2/ANGPT1 ratio was decreased during angioedema attacks.
the reported paired ratio comparison supports the direction, though the small acute subgroup limits precision
Abstract; Results §3.1; Figure 1D
SecondaryTentative
several vasoactive mediators are implicated not only in the pathophysiology of C1-INH-HAE, but also in the resolution of increased vascular permeability during angioedema attack.
single-time-point observational measurements cannot identify a mediator role in attack resolution
Discussion, final paragraph
Derived from the full evaluation — not a separate score.
Strengths · Limitations
Strengths
Novel acute mediator observations
The study reports increased ANGPT1 and reduced PAF-AH activity during attacks while also reporting null findings for several VEGFs and ANGPT2.
↳ Results §§3.1–3.2; Figures 1–2
Clear connection to prior biology
The introduction and discussion relate the findings to bradykinin, endothelial activation, prior remission-phase mediator studies, and ANGPT1/Tie2 biology.
↳ Introduction; Discussion, paragraphs 1–3
Limitations
Small selectively observed attack subgroup
Only 15 of 51 remission participants were also followed during an acute attack, without an account of subgroup selection or comparison with those lacking attack samples.
↳ Methods §2.2
Acute treatment effects remain unaddressed
Attack samples were obtained within six hours of symptom onset, but the article does not report whether on-demand treatment occurred before collection or discuss its possible influence.
↳ Methods §2.2; Discussion
Resolution inference exceeds study design
A single early attack-phase measurement can describe mediator differences but cannot establish that those mediators participate in resolving vascular permeability.
↳ Discussion, final paragraph
Nabu Commentary
The paired attack-remission design and six-hour sampling window make the study suitable for describing acute changes in circulating mediators. Its contribution remains narrow because the central analysis includes 15 patients and does not determine whether observed changes cause, follow, or resolve attacks. Confidence is further limited by the absence of an account of attack-subgroup selection and treatment before sampling. The discussion engages relevant vascular-permeability literature, but its final resolution-oriented conclusion is stronger than the observational design supports.
Check another paper
Author Note / Field Feedback
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Dimension breakdown
Study Quality
Limited2.9
Confidence mediumContribution
3.1
The study adds paired attack-versus-remission measurements for several vasoactive mediators and identifies increased ANGPT1 and decreased PAF-AH activity during attacks. The advance is incremental and descriptive rather than mechanistically resolving attack evolution or resolution.
Introduction, final paragraphs; Results §§3.1–3.2
“To date, there are no data on the role of VEGFs, ANGPTs and PAF-AH during angioedema attacks.”
Methodological Rigour
2.6
Within-person comparisons and sampling within six hours of symptom onset fit the descriptive question, and technicians were blinded to patient history. Confidence is reduced because only 15 of 51 patients supplied attack samples and selection, acute treatment, and other acute-phase measurement influences were not addressed.
Methods §§2.1–2.2
“Fifteen patients out of 51 were followed also during acute angioedema attack”
Reporting
3.4
The paper follows a clear progression from mediator biology through paired results to interpretation, and most result statements accurately describe observed differences. The concluding claim that mediators are implicated in resolution is stronger than can be established from one early attack-phase measurement.
Abstract; Discussion, final paragraph
“several vasoactive mediators are implicated…in the resolution of increased vascular permeability”
Positioning
3.1
The article relates its findings to bradykinin biology, endothelial activation, prior remission-phase findings, and ANGPT1 genetics. It does not explicitly trace the small acute subgroup, possible treatment timing, multiple comparisons, or observational design into the certainty of its resolution hypothesis.
Introduction; Discussion, paragraphs 1–3 and final paragraph
“The explanation of this observation is still unclear.”
Reliability
Caveats4 of 4 checks
Internal CoherenceNoted
Minor reporting inconsistencies reduce auditability without materially changing the principal biomarker comparisons. The concerns involve figure-summary descriptions and unshown secondary analyses rather than contradictions in the headline results.
Research ConductClean
Ethics approval, written informed consent, and competing-interest disclosure are stated. No supplied-text evidence indicates a research-conduct concern.
Flags: 2 declared / 5 total
Reference IntegrityClean
28 of 28 checkable references verified
28 references in manuscript
Post-Publication RecordClean
No retraction notice found in Retraction Watch.
Last checked: 18 Sep 2026
Sources: Retraction Watch ✓
Readiness
Where this paper’s evidence sits on the path from initial observation to real-world use.
Mechanistic
The findings remain exploratory associations between attack state and plasma mediators. No diagnostic threshold, prospective prediction model, therapeutic intervention, or biomarker-guided action is developed or tested.
Methods §2.2; Results §§3.1–3.2; Discussion
“The explanation of this observation is still unclear.”
AI-generated, human-governed. Something look off? Contact us to request a review.